Clinical Trial Update: A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating idasanutlin in combination with chemotherapy or venetoclax in pediatric and young adult relapsed/refractory acute leukemias and solid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Neuroblastoma
• Solid Tumors

Drugs mentioned

• Idasanutlin (Idasanutlin)
• Venetoclax (venetoclax)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-12-20